Pfizer's COVID-19 pill, Paxlovid, cuts hospitalizations, deaths by 89%

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

Health Health Headlines News

'An extraordinary effect': Pfizer says its COVID-19 pill reduced the risk of hospitalization and death by 89% in high-risk patients

Pfizer's experimental coronavirus pill slashed the risk of hospitalization and death by 89% among high-risk people recently infected with COVID-19, the New York drugmaking giant said Friday.

"This should really break the fear, reduce the tremendous burden on hospitals, and the risk that, if you get infected, you'll end up in a hospital and die is statistically becoming smaller and smaller and almost non-existent," he added."It's a huge medical advance for humanity." An early look at the study's results included data from 774 adults who enrolled, were at high risk of severe COVID-19 and were recently infected. Volunteers were randomly assigned to get Pfizer's antiviral or a placebo. Among those taking Pfizer's drug, less than 1% were hospitalized and none died. In the placebo group, about 7% of people were hospitalized and there were 10 deaths.

"I would say this is as close as you can come with an antiviral to short-term, cure-like outcomes," Dolsten said, adding he was expecting a good antiviral to show 70% or more efficacy."It's an extraordinary effect."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

LaurelBlu2 Just listened to his conversation w/JohnBerman on CNN excellent!

The business of Pfizer is business. Extraordinary isn't it?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in HEALTH

Health Health Latest News, Health Health Headlines